1. Additive effects of the Rho kinase inhibitor Y‐27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure. (21st November 2016) Authors: Uvin, Pieter; Albersen, Maarten; Bollen, Ine; Falter, Maarten; Weyne, Emmanuel; Linsen, Loes; Tinel, Hanna; Sandner, Peter; Bivalacqua, Trinity J.; De Ridder, Dirk J. M. K.; Van der Aa, Frank; Brône, Bert; Van Renterghem, Koenraad Journal: BJU international Issue: Volume 119:Number 2(2017) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Age, noise and cGMP: Pharmacological activation of soluble guanylyl cyclase (sGC) interacts with the progression of age related and noise induced hearing loss. Issue 1 (December 2015) Authors: Rüttiger, Lukas; Varakina, Ksenia; Möhrle, Dorit; Bing, Dan; Sandner, Peter; Knipper, Marlies Journal: BMC pharmacology & toxicology Issue: Volume 16:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence. (January 2017) Authors: Sandner, Peter; Stasch, Johannes Peter Journal: Respiratory medicine Issue: Volume 122(2017)Supplement 1 Page Start: S1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. Issue 4 (15th February 2022) Authors: Zabbarova, Irina V; Ikeda, Youko; Kozlowski, Mark G; Tyagi, Pradeep; Birder, Lori A; Chakrabarty, Basu; Perera, Subashan KPG; Dhir, Rajiv; Straub, Adam C; Sandner, Peter; Andersson, Karl‐Erik; Drake, Marcus J; Fry, Christopher H; Kanai, Anthony J Journal: Journal of pathology Issue: Volume 256:Issue 4(2022) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emerging strategies for treatment of systemic sclerosis. Issue 2 (May 2016) Authors: Khanna, Dinesh; Distler, Jörg H.W.; Sandner, Peter; Distler, Oliver Journal: Journal of scleroderma and related disorders Issue: Volume 1:Issue 2(2016) Page Start: 186 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Heart failure. ([2017]) Editors: Bauersachs, Johann; Butler, Javed; Sandner, Peter Record Type: Book Extent: 1 online resource (ix, 581 pages), illustrations (some color) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis. Issue 4 (1st March 2017) Authors: Schinner, Elisabeth; Wetzl, Veronika; Schramm, Andrea; Kees, Frieder; Sandner, Peter; Stasch, Johannes‐Peter; Hofmann, Franz; Schlossmann, Jens Journal: FEBS open bio Issue: Volume 7:Issue 4(2017) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts. (27th December 2019) Authors: Menges, Lukas; Krawutschke, Christian; Füchtbauer, Ernst‐Martin; Füchtbauer, Annette; Sandner, Peter; Koesling, Doris; Russwurm, Michael Journal: British journal of pharmacology Issue: Volume 176:Number 24(2019) Page Start: 4696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy. (18th September 2020) Authors: Lowe, Jeovanna; Kolkhof, Peter; Haupt, Michael J.; Peczkowski, Kyra K.; Rastogi, Neha; Hauck, J. Spencer; Kadakia, Feni K.; Zins, Jonathan G.; Ciccone, Pierce C.; Smart, Suzanne; Sandner, Peter; Raman, Subha V.; Janssen, Paul M.L.; Rafael‐Fortney, Jill A. Journal: ESC heart failure Issue: Volume 7:Number 6(2020) Page Start: 3983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney. (3rd July 2021) Authors: Stehle, Daniel; Xu, Min Ze; Schomber, Tibor; Hahn, Michael G.; Schweda, Frank; Feil, Susanne; Kraehling, Jan R.; Eitner, Frank; Patzak, Andreas; Sandner, Peter; Feil, Robert; Bénardeau, Agnès Other Names: Lukowski Robert guestEditor.; Feil Robert guestEditor. Journal: British journal of pharmacology Issue: Volume 179:Number 11(2022) Page Start: 2476 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗